Form 4 for CI Cigna
Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-22 · accession 0001225208-23-002821 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-24 | 2023-02-22 | CI | Eder Noelle K | EVP, Gbl CIO | A - Grant | $0.00 | +2,855 | 14.4K | +25% | $0 |
| D | 2023-02-24 | 2023-02-22 | CI | Eder Noelle K | EVP, Gbl CIO | A - Grant | $0.00 | +10.5K | 10.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.01 Par Value | 2023-02-22 | A | A | 2,855 | $0.00 | 14,366 | D | — | — | (F1) These restricted shares vest in three equal annual installments beginning March 1, 2024. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2023-02-22 | A | A | 10,549 | $0.00 | 10,549 | D | $294.61 · 2024-03-01 to 2033-02-22 | 10,549 Common Stock, $.01 Par Value | (F3) This option vests in three equal annual installments beginning March 1, 2024. |